ASAM Stimulant Use Disorder Course

Thursday, April 24, 2025
9:00 am – 4:30 pm

*Not included with the full conference; separate registration required

Overview

Effectively managing stimulant use disorder requires a comprehensive, patient-centered approach. This course equips healthcare professionals with the understanding and information to inform use of evidence-based tools to diagnose and treat stimulant use disorder, including harm reduction strategies, behavioral interventions, pharmacological treatments, and the management of acute intoxication. Special considerations for long-term health impacts and co-occurring medical or psychiatric conditions are also addressed, ensuring practitioners are prepared to deliver or incorporate holistic care across various clinical settings and levels of care.

Who Should Attend

This course is for healthcare professionals, including physicians, psychologists, and addiction specialists, who provide care to patients with stimulant use disorder (SUD).

Learning Objectives

Upon completion of this educational activity, participants should be able to:

Identify the unique neurobiological and psychosocial characteristics of stimulant use disorder that differentiate it from other substance use disorders. 
Apply evidence-based harm reduction strategies and behavioral interventions to engage patients in stimulant use disorder treatment. 
Develop comprehensive treatment plans for behavioral interventions and pharmacological treatments in various clinical settings for managing stimulant use disorder. 
Implement treatments for both acute intoxication and long-term management of patients with stimulant use disorder, including those with co-occurring medical or psychiatric conditions.

Program Planning

Carla Marienfeld, MD, DFAPA, FASAM (Chair)

Dominick DePhilippis, PhD

Jeffrey Devido, MD, MTS, FASAM

Brian Hurley, MD, MBA, FAPA, DFASAM

Raagini Jawa, MD, MPH, FASAM

Eve Lasswell, PsD

Stephen Murray, MPH, NRP

Siddarth Puri, MD, FASAM